237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer
Antonio Gonzalez Martín, B. Slomovitz, K. Fujiwara, E. Kalbacher, A. Bagameri, S. Ghamande, Jung-Yun Lee, S. Banerjee, F.C. Maluf, Domenica Lorusso, K. Yonemori, E. Nieuwenhuysen, Luis Manso Sánchez, L. Woelber, A.M. Westermann, A. Covens, E. Whalley, Melinda Siew Leng Teng, I. Soumaoro, I. Vergote
{"title":"237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer","authors":"Antonio Gonzalez Martín, B. Slomovitz, K. Fujiwara, E. Kalbacher, A. Bagameri, S. Ghamande, Jung-Yun Lee, S. Banerjee, F.C. Maluf, Domenica Lorusso, K. Yonemori, E. Nieuwenhuysen, Luis Manso Sánchez, L. Woelber, A.M. Westermann, A. Covens, E. Whalley, Melinda Siew Leng Teng, I. Soumaoro, I. Vergote","doi":"10.1136/ijgc-2024-esgo.7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"71 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
